John Valliant

Net worth: 7 M $ as of 2024-03-30

54 year

Health Technology

Consumer Services

Profile

John Valliant is the founder of Fusion Pharmaceuticals, Inc. (2014) and Centre For Probe Development & Commercialization (2008), where he holds the titles of Chief Executive Officer & Director and Independent Director & Principal Investigator, respectively.
He is currently a Professor at McMaster University, a position he has held since 1999.
Dr. Valliant earned a doctorate degree from McMaster University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
FUSION PHARMACEUTICALS INC 0.38%	2024-01-03	318,147 ( 0.38% )	7 M $	2024-03-30

John Valliant active positions

Companies	Position	Start
FUSN PHAR	Founder	2014-11-30
Centre For Probe Development & Commercialization Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.	Founder	2008-02-29
McMaster University	Corporate Officer/Principal	1998-12-31

All active positions of John Valliant

Training of John Valliant

McMaster University

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Valliant's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
FUSN PHAR	Health Technology

Private companies	1
Centre For Probe Development & Commercialization Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.	Health Technology